retatrutide trial weight loss results 🚨 BREAKING: Shows “Bariatric-Level” in Phase 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide Results: 24% Weight Loss
Description
van der Velden, W
Diabetic Med (2022) 39(3):e14780
One is that GLP-1s might help to reduce inflammation in the brain and body, says Paul Newhouse, MD , director of the Vanderbilt Center for Cognitive Medicine
Glucagon infusion studies in humans have shown that acute glucagon administration increases energy expenditure by approximately 15-20% above baseline
They slow down gastric emptying, increase satiety, and suppress hunger signals from your brain
Personal preference: Some patients may simply wish to move away from long-term pharmacological management
